Biotron Statistics
Total Valuation
Biotron has a market cap or net worth of 2.54 million. The enterprise value is 1.98 million.
| Market Cap | 2.54M |
| Enterprise Value | 1.98M |
Important Dates
The next estimated earnings date is Thursday, May 29, 2025.
| Earnings Date | May 29, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.11% |
| Shares Change (QoQ) | +9.94% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 1.10B |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.26 |
| PB Ratio | 8.95 |
| P/TBV Ratio | 8.95 |
| P/FCF Ratio | 22.97 |
| P/OCF Ratio | 22.58 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -2.26 |
| EV / Sales | 1.71 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 17.90 |
Financial Position
The company has a current ratio of 1.83
| Current Ratio | 1.83 |
| Quick Ratio | 1.75 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -94.80 |
Financial Efficiency
Return on equity (ROE) is -121.67% and return on invested capital (ROIC) is -76.25%.
| Return on Equity (ROE) | -121.67% |
| Return on Assets (ROA) | -51.97% |
| Return on Invested Capital (ROIC) | -76.25% |
| Return on Capital Employed (ROCE) | -313.06% |
| Revenue Per Employee | 374,300 |
| Profits Per Employee | -292,115 |
| Employee Count | 3 |
| Asset Turnover | 1.05 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -95.38% in the last 52 weeks. The beta is -0.60, so Biotron's price volatility has been lower than the market average.
| Beta (5Y) | -0.60 |
| 52-Week Price Change | -95.38% |
| 50-Day Moving Average | 0.01 |
| 200-Day Moving Average | 0.02 |
| Relative Strength Index (RSI) | 14.87 |
| Average Volume (20 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Biotron had revenue of 1.12 million and -876,345 in losses. Loss per share was -0.00.
| Revenue | 1.12M |
| Gross Profit | 1.12M |
| Operating Income | -889,312 |
| Pretax Income | -876,345 |
| Net Income | -876,345 |
| EBITDA | -897,164 |
| EBIT | -889,312 |
| Loss Per Share | -0.00 |
Balance Sheet
The company has 543,896 in cash and n/a in debt, giving a net cash position of 543,896.
| Cash & Cash Equivalents | 543,896 |
| Total Debt | n/a |
| Net Cash | 543,896 |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 284,073 |
| Book Value Per Share | 0.00 |
| Working Capital | 258,633 |
Cash Flow
In the last 12 months, operating cash flow was 112,625 and capital expenditures -1,900, giving a free cash flow of 110,725.
| Operating Cash Flow | 112,625 |
| Capital Expenditures | -1,900 |
| Free Cash Flow | 110,725 |
| FCF Per Share | n/a |
Margins
Gross margin is 100.00%, with operating and profit margins of -79.20% and -78.04%.
| Gross Margin | 100.00% |
| Operating Margin | -79.20% |
| Pretax Margin | -78.04% |
| Profit Margin | -78.04% |
| EBITDA Margin | -79.90% |
| EBIT Margin | -79.20% |
| FCF Margin | 9.86% |
Dividends & Yields
Biotron does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.11% |
| Shareholder Yield | -0.11% |
| Earnings Yield | -34.46% |
| FCF Yield | 4.35% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Biotron has an Altman Z-Score of -34.73. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -34.73 |
| Piotroski F-Score | n/a |